Intensity Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Intensity Therapeutics is planning a public offering of common stock and warrants to raise capital for clinical trials and general corporate purposes.
NASDAQ
Intensity Therapeutics is launching a public offering to sell shares of common stock and warrants, aiming to raise capital for clinical trials and general corporate purposes.
NASDAQ
Intensity Therapeutics is registering for resale 1,237,113 shares of common stock issuable upon the exercise of warrants previously acquired by a selling stockholder.